Invention Grant
- Patent Title: Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry
-
Application No.: US14936847Application Date: 2015-11-10
-
Publication No.: US10037874B2Publication Date: 2018-07-31
- Inventor: Joanna Röder , Carlos Oliveira , Julia Grigorieva , Heinrich Röder , Devalingam Mahalingam
- Applicant: Biodesix, Inc.
- Applicant Address: US CO Boulder US TX Austin
- Assignee: Biodesix, Inc.,The Board of Regents of the University of Texas System
- Current Assignee: Biodesix, Inc.,The Board of Regents of the University of Texas System
- Current Assignee Address: US CO Boulder US TX Austin
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: H01J49/00
- IPC: H01J49/00 ; H01J49/16 ; G01N33/574 ; G01N33/68 ; G06K9/62 ; G16H50/70 ; G16H10/40 ; G06K9/00

Abstract:
Hepatocellular carcinoma (HCC) is detected in a patient with liver disease. Mass spectrometry data from a blood-based sample from the patient is compared to a reference set of mass-spectrometry data from a multitude of other patients with liver disease, including patients with and without HCC, in a general purpose computer configured as a classifier. The classifier generates a class label, such as HCC or No HCC, for the test sample. A laboratory system for early detection of HCC in patients with liver disease is also disclosed. Alternative testing strategies using AFP measurement and a reference set for classification in the form of class-labeled mass spectral data from blood-based samples of lung cancer patients are also described, including multi-stage testing.
Public/Granted literature
- US20160163522A1 Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF Mass Spectrometry Public/Granted day:2016-06-09
Information query